AU2002219789A1 - Methods for analyzing dynamic changes in cellular informatics - Google Patents
Methods for analyzing dynamic changes in cellular informaticsInfo
- Publication number
- AU2002219789A1 AU2002219789A1 AU2002219789A AU1978902A AU2002219789A1 AU 2002219789 A1 AU2002219789 A1 AU 2002219789A1 AU 2002219789 A AU2002219789 A AU 2002219789A AU 1978902 A AU1978902 A AU 1978902A AU 2002219789 A1 AU2002219789 A1 AU 2002219789A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- dynamic changes
- analyzing dynamic
- cellular informatics
- informatics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/10—Boolean models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24200900P | 2000-10-20 | 2000-10-20 | |
US60/242,009 | 2000-10-20 | ||
PCT/US2001/043041 WO2002037102A2 (en) | 2000-10-20 | 2001-10-19 | Methods for analyzing dynamic changes in cellular informatics |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002219789A1 true AU2002219789A1 (en) | 2002-05-15 |
Family
ID=22913104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002219789A Abandoned AU2002219789A1 (en) | 2000-10-20 | 2001-10-19 | Methods for analyzing dynamic changes in cellular informatics |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020155422A1 (en) |
EP (1) | EP1328808A2 (en) |
AU (1) | AU2002219789A1 (en) |
WO (1) | WO2002037102A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673554B1 (en) * | 1999-06-14 | 2004-01-06 | Trellie Bioinformatics, Inc. | Protein localization assays for toxicity and antidotes thereto |
US8000949B2 (en) * | 2001-06-18 | 2011-08-16 | Genego, Inc. | Methods for identification of novel protein drug targets and biomarkers utilizing functional networks |
US7415359B2 (en) * | 2001-11-02 | 2008-08-19 | Gene Network Sciences, Inc. | Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents |
ES2307832T3 (en) * | 2001-12-03 | 2008-12-01 | Amgen Fremont Inc. | ANTIBODY CLASSIFICATION BASED ON THE CHARACTERISTICS OF UNION. |
JP2005512043A (en) * | 2001-12-03 | 2005-04-28 | アブジェニックス・インコーポレーテッド | Discovery of therapeutic products |
WO2003048730A2 (en) * | 2001-12-03 | 2003-06-12 | Abgenix, Inc. | Identification of high affinity molecules by limited dilution screening |
US7877273B2 (en) * | 2002-01-08 | 2011-01-25 | Fredric David Abramson | System and method for evaluating and providing nutrigenomic data, information and advice |
DE10342274B4 (en) * | 2003-09-12 | 2007-11-15 | Siemens Ag | Identify pharmaceutical targets |
DE10344345B3 (en) | 2003-09-24 | 2005-05-12 | Siemens Ag | Method for communication in an ad hoc radio communication system |
US8095389B2 (en) * | 2006-07-17 | 2012-01-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Computer systems and methods for selecting subjects for clinical trials |
US20080228699A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Creation of Attribute Combination Databases |
EP3276526A1 (en) | 2008-12-31 | 2018-01-31 | 23Andme, Inc. | Finding relatives in a database |
US20110059861A1 (en) * | 2009-09-08 | 2011-03-10 | Nodality, Inc. | Analysis of cell networks |
CA2883521A1 (en) * | 2012-09-11 | 2014-03-20 | Theranos, Inc. | Information management systems and methods using a biological signature |
EP2944958A1 (en) * | 2014-04-04 | 2015-11-18 | Techno-Path (Distribution) | A method of predicting phenotypic instability in a cell |
EP3075844A1 (en) | 2015-04-01 | 2016-10-05 | Valitacell Limited | A method of determining a compositional or functional characteristic of a cell culture media |
EP3338209A1 (en) * | 2015-08-17 | 2018-06-27 | Siemens Healthcare GmbH | Method and system for disease progression modeling and therapy optimizing for individual patients |
US20200020419A1 (en) * | 2018-07-16 | 2020-01-16 | Flagship Pioneering Innovations Vi, Llc. | Methods of analyzing cells |
GB202107576D0 (en) * | 2021-05-27 | 2021-07-14 | Univ Dublin | Molecular evaluation methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965352A (en) * | 1998-05-08 | 1999-10-12 | Rosetta Inpharmatics, Inc. | Methods for identifying pathways of drug action |
US6132969A (en) * | 1998-06-19 | 2000-10-17 | Rosetta Inpharmatics, Inc. | Methods for testing biological network models |
-
2001
- 2001-10-19 AU AU2002219789A patent/AU2002219789A1/en not_active Abandoned
- 2001-10-19 WO PCT/US2001/043041 patent/WO2002037102A2/en not_active Application Discontinuation
- 2001-10-19 EP EP01992887A patent/EP1328808A2/en not_active Withdrawn
- 2001-10-19 US US09/985,963 patent/US20020155422A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2002037102A2 (en) | 2002-05-10 |
US20020155422A1 (en) | 2002-10-24 |
WO2002037102A3 (en) | 2003-03-20 |
EP1328808A2 (en) | 2003-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002219789A1 (en) | Methods for analyzing dynamic changes in cellular informatics | |
AU2002224831A1 (en) | Kit and method for determining multiple analytes | |
AU2001259139A1 (en) | Method and apparatus for predictive cellular bioinformatics | |
HK1174178A1 (en) | Method for use in an access point (ap) and an access point (ap) (ap)(ap) | |
EP1271099A3 (en) | Method and arrangement for determining movement | |
GB0031566D0 (en) | Methods for spectral analysis and their applications | |
AU2003281419A1 (en) | Enhancing dynamic characteristics in an analytical model | |
AU2001288889A1 (en) | Information sharing and analysis system and method | |
AU2002214419A1 (en) | Method for structuring and searching information | |
IL183717A0 (en) | Low dielectric materials and methods for making same | |
AU2001224349A1 (en) | Proteomic analysis | |
AU2001243298A1 (en) | Apparatus and method for determining position | |
AU2001273730A1 (en) | Sample for simultaneously conducting electro-chemical and topographic near-fieldmicroscopy | |
AU3229601A (en) | Compression tester | |
AU2001249151A1 (en) | System and method for simulating cellular biochemical pathways | |
AU2001279850A1 (en) | Method and arrangement for studsystem | |
AU2001264660A1 (en) | Method for determining fluctuation in attentional state and overall attentional state | |
AU2001265266A1 (en) | Microcolumn for use in sample extraction | |
AU2002221740A1 (en) | Method for analyzing proteins | |
AU2001266169A1 (en) | Predicting changes in characteristics of an object | |
AU2001266035A1 (en) | Method and device for performing analyses in parallel | |
AP2003002714A0 (en) | Assaying method | |
AU2001231803A1 (en) | Method in trade | |
AU2002213982A1 (en) | Device for determining skin aging in vitro | |
AU2001259603A1 (en) | Method and apparatus for determining local viscoelasticity |